Angela L. Swampillai
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2026
A Randomized, Phase II Clinical Trial of FLT-PET and FDG-PET for Early Response Assessment of Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 10, 2026
Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: January 08, 2026
Antiepileptic drugs in glioblastoma survival: dichotomic or treatment and mechanism of action-dependent variable?
Journal: Neuro-oncology advances
Published: October 01, 2025
Real world study of sacituzumab govitecan in metastatic triple-negative breast cancer in the United Kingdom.
Journal: British journal of cancer
Published: October 27, 2023
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Journal: Breast cancer research and treatment
Published: July 14, 2023
Overcoming challenges of translating deep-learning models for glioblastoma: the ZGBM consortium.
Journal: The British journal of radiology
Published: May 26, 2022
Reliability of functional outcome measures in adults with neurofibromatosis 2.
Journal: SAGE open medicine
Published: March 17, 2022
Last Updated: 09/26/2026